Skip to content
10-Q

Quarterly Report

Bone Biologics Corp BBLG BBLGW

0001493152-25-023563

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 1.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 965.8K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 292.32K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 199.47K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.98M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$2.77M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.02M
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.6M
Stockholders Equity Q3 2025 · Mar 31, 2025 $2.91M
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.48M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.79M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.91M
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.67M
Stockholders Equity Q3 2025 · Dec 31, 2023 $2.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $334.28K
Current Liabilities Q3 2025 · Dec 31, 2024 $377.71K
Total Liabilities Q3 2025 · Sep 30, 2025 $334.28K
Total Liabilities Q3 2025 · Dec 31, 2024 $377.71K
Current Assets Q3 2025 · Sep 30, 2025 $6.35M
Current Assets Q3 2025 · Dec 31, 2024 $3.86M
Total Assets Q3 2025 · Sep 30, 2025 $6.35M
Total Assets Q3 2025 · Dec 31, 2024 $3.86M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.51
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$14.21
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$29.09
Eps Basic Q3 2025 · Sep 30, 2025 −$0.37
Eps Basic Q3 2025 · Sep 30, 2025 −$2.51
Eps Basic restated Q3 2025 · Sep 30, 2024 −$14.21
Eps Basic restated Q3 2025 · Sep 30, 2024 −$29.09
Sga Expense Q3 2025 · Sep 30, 2025 $527.47K
Sga Expense Q3 2025 · Sep 30, 2025 $1.7M
Sga Expense Q3 2025 · Sep 30, 2024 $521.27K
Sga Expense Q3 2025 · Sep 30, 2024 $1.64M
Rd Expense Q3 2025 · Sep 30, 2025 $187.81K
Rd Expense Q3 2025 · Sep 30, 2025 $802.99K
Rd Expense Q3 2025 · Sep 30, 2024 $429.75K
Rd Expense Q3 2025 · Sep 30, 2024 $1.03M
Net Income Q3 2025 · Sep 30, 2025 −$666.74K
Net Income Q3 2025 · Sep 30, 2025 −$2.42M
Net Income Q3 2025 · Jun 30, 2025 −$740.52K
Net Income Q3 2025 · Mar 31, 2025 −$1.02M
Net Income Q3 2025 · Sep 30, 2024 −$941K
Net Income Q3 2025 · Sep 30, 2024 −$2.59M
Net Income Q3 2025 · Jun 30, 2024 −$783.73K
Net Income Q3 2025 · Mar 31, 2024 −$865.97K
Operating Income Q3 2025 · Sep 30, 2025 −$715.27K
Operating Income Q3 2025 · Sep 30, 2025 −$2.5M
Operating Income Q3 2025 · Sep 30, 2024 −$951.02K
Operating Income Q3 2025 · Sep 30, 2024 −$2.66M